geoopen
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 platform trial
GEO Series GSE173839. Homo sapiens. 105 samples. Type: Expression profiling by array.
ShareScore
24/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 8
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8